Navigation Links
ORTHOCON® Names David J. Hart Vice President of Business Operations
Date:3/15/2012

IRVINGTON, N.Y., March 15, 2012 /PRNewswire/ -- ORTHOCON®, Inc., a privately-held surgical device company, today announced that David J. Hart has been appointed Vice President of Business Operations. Mr. Hart will be responsible for in-licensing and acquiring new products and technologies for development and distribution by ORTHOCON's R&D and commercial teams. 

Mr. Hart joins ORTHOCON from Alpine Capital Group, a leading family office investment fund where, as President and Chief Investment Officer, he was responsible for all private equity and indirect capital investments and healthcare research. Prior to Alpine Capital, David was Principal and Senior Research Analyst at Apelles Investment Management, a cross-capital healthcare investment fund focused on public and private investing in medical device, healthcare service, and healthcare information technology companies. Mr. Hart began his career in the merger and acquisition groups at Thomas Weisel and Partners and Duff and Phelps. He earned a MBA from Columbia University and a BA from Duke where he was a member of the varsity golf team.

"I am thrilled to have David on our senior leadership team," said John J. Pacifico, President and Chief Executive Officer of ORTHOCON. "Having known David for several years and watched him achieve tremendous professional success directly relevant to ORTHOCON's business plan, I know he is perfect for this role and I fully expect him to add significant value to ORTHOCON and to our shareholders."

"I've had the opportunity to watch ORTHOCON evolve over the last five years. John has built a dynamic organization with a robust R&D pipeline and a truly differentiated commercialization strategy," said David Hart. "I am excited to join the ORTHOCON team and look forward to helping John execute on his strategic vision for the company."

About ORTHOCON
Founded in 2005, ORTHOCON develops, acquires, manufactures, and markets surgical products. In 2011, ORTHOCON announced the commercial introduction of its first FDA cleared product, Hemasorb Resorbable Hemostatic Bone Putty, and the clearance of Hemasorb Apply, a proprietary applicator designed to deliver Hemasorb and other ORTHOCON products presently under development. Also in 2011, ORTHOCON announced a strategic partnership with Bezwada Biomedical which gave ORTHOCON worldwide rights to develop and market Bezwada's absorbable polyurethane technology for bone applications. 

ORTHOCON is funded by leading international venture capital investment firms. The company occupies 8,000 square feet at its state-of-the-art facility in Irvington, New York. For more information, please visit www.orthocon.com.


'/>"/>
SOURCE ORTHOCON, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ORTHOCON®, Inc. Receives 510(k) Clearance to Market HEMASORB Apply™
2. ORTHOCON® Receives CE Mark and Health Canada Medical Device License for HEMASORB®
3. ORTHOCON® Announces U.S. Market Launch of HEMASORB®
4. Zeus Healthcare Names Larry Havelis as CEO
5. RoundTable Healthcare Partners Names Kent J. Davies CEO of Newly Formed Platform Development Corporation
6. InterMune Names Jonathan A. Leff, M.D., as Executive Vice President of Research and Development
7. SalesCongo Names Ken Kaisen CEO
8. UNT System Names Jacobson Founding Dean of College of Pharmacy
9. LoneStar Heart Inc. Names Andrew J. Coats, M.D., and Mark Maciejewski to Its Board of Directors
10. Premier Research Names Etienne Drouet Executive Director, Oncology Europe
11. Premier Research Names Susan Stansfield, PhD Executive VP, Clinical Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2017)... , Jan. 14, 2017  Johnson & Weaver, LLP announces ... purchasers of Zimmer Biomet Holdings, Inc. (NYSE: ZBH ... October 31, 2016 (the "Class Period"). Zimmer Biomet ... markets orthopaedic reconstructive products, such as knee and hip reconstructive ... ...
(Date:1/13/2017)... , January 13, 2017 Stock-Callers is ... Medical Group N.V. (NASDAQ: WMGI ), Varian Medical ... (NASDAQ: MDXG ), and NuVasive Inc. (NASDAQ: ... which fell back to a negative finish on Thursday, January ... falling about 0.1%, while shares of health care companies in ...
(Date:1/13/2017)...  Alfalfa, cattle, leafy greens and rosy cheeked children share ... which emphasizes the food industry,s shift from response to prevention. ... COPAN,s Swab Rinse Kit (SRK™) is ... in the wake of the new FDA Food Safety ... is expanding the U.S. production of the SRK line ...
Breaking Medicine Technology:
(Date:1/16/2017)... , ... January 16, 2017 , ... ... been appointed Chief Executive Officer of the medical device company, effective immediately. , ... Robert Storey. “Kevin has a strong track record in medical device market ...
(Date:1/15/2017)... , ... January 15, 2017 , ... In this role, ... the United States for the asthma & allergy friendly mark. This certification program was ... test and identify consumer products to be more suitable for the 60+ million people ...
(Date:1/15/2017)... ... 2017 , ... Whole Health Supply, LLC is announcing the release of an updated version of ... purchase. , The 2017 edition has wide jaws that will accommodate nails up to ... well as diabetics. This handle is reinforced for extra strength when pressing down on dense ...
(Date:1/15/2017)... ... January 15, 2017 , ... "On Tour is a music ... customization and ease," said Christina Austin - CEO of Pixel Film Studios. , ... can edit the style and animation of their slideshows. Place each slide on top ...
(Date:1/15/2017)... ... ... Wondering where to go this Valentine's Day? Well, there is a solution to ... feast in the comfort of your own home. Lobster Gram is introducing two new ... until February 15th, 2017. , Romantic Dinner one is Lobster Gram's "Love at ...
Breaking Medicine News(10 mins):